阿片类物质所致焦虑障碍
Opioid-induced anxiety disorder
- 层级
- 6 级
定义
阿片类药物所致焦虑障碍的特点是在阿片类药物中毒或戒断期间或之后不久出现的焦虑症状(例如,忧虑或担忧、恐惧、自主神经过度唤醒的生理症状、回避行为)。症状强度或持续时间大大超过了阿片类药物中毒或阿片类药物戒断的焦虑症状。阿片类药物的使用量和持续时间必须能够产生焦虑症状。这些症状不能用原发性精神障碍(例如,焦虑和恐惧相关障碍、具有突出焦虑症状的抑郁症)更好地解释,如果焦虑症状发生在使用阿片类药物之前,如果症状在阿片类药物停止使用或停药后持续很长时间,或者,如果有其他证据表明先前存在具有焦虑症状的原发性精神障碍(例如,与阿片类药物使用无关的既往发作史),则可能是这种情况。
Opioid-induced anxiety disorder is characterised by anxiety symptoms (e.g., apprehension or worry, fear, physiological symptoms of excessive autonomic arousal, avoidance behaviour) that develop during or soon after intoxication with or withdrawal from opioids. The intensity or duration of the symptoms is substantially in excess of anxiety symptoms that are characteristic of Opioid intoxication or Opioid withdrawal. The amount and duration of opioid use must be capable of producing anxiety symptoms. The symptoms are not better explained by a primary mental disorder (e.g., an Anxiety and Fear-Related Disorder, a Depressive Disorder with prominent anxiety symptoms), as might be the case if the anxiety symptoms preceded the onset of the opioid use, if the symptoms persist for a substantial period of time after cessation of the opioid use or withdrawal, or if there is other evidence of a pre-existing primary mental disorder with anxiety symptoms (e.g., a history of prior episodes not associated with opioid use).
索引词 可用于检索该条目的同义词与别名
- 阿片类物质所致焦虑障碍
- 阿片类物质戒断所致焦虑障碍
英文词条(2)
- Opioid-induced anxiety disorder
- Opioid withdrawal-induced anxiety disorder
后组配轴 Postcoordination
后组配是在主干编码之后追加的可选扩展轴(如侧别、具体解剖部位、严重程度),用于把「部位 + 侧别 + 病程」等细节一次表达完整。只有标注「必填」的轴在组合编码时必须给出,其余可留空。
- 相关疾患associatedWith可选
- 病因hasCausingCondition必填